Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emmaus Life Sciences Inc (EMMA)

Emmaus Life Sciences Inc (EMMA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 79,008
  • Shares Outstanding, K 48,471
  • Annual Sales, $ 6,080 K
  • Annual Income, $ -26,140 K
  • 60-Month Beta 2.68
  • Price/Sales 13.54
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.84
  • Number of Estimates 1
  • High Estimate -0.84
  • Low Estimate -0.84
  • Prior Year -1.92
  • Growth Rate Est. (year over year) +56.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6200 +0.62%
on 01/21/20
2.2400 -27.23%
on 12/26/19
-0.3600 (-18.09%)
since 12/20/19
3-Month
1.6200 +0.62%
on 01/21/20
3.2500 -49.85%
on 11/04/19
-1.0200 (-38.49%)
since 10/22/19
52-Week
1.3300 +22.56%
on 09/24/19
12.9000 -87.36%
on 02/04/19
-7.7300 (-82.59%)
since 01/22/19

Most Recent Stories

More News
Emmaus Life Sciences Announces a New Adherence Program for Its Sickle Cell Disease Patients

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, is pleased to announce a new adherence program available to sickle cell disease (SCD) patients in collaboration with...

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Announces First Purchase Order from its Partnership with taiba Healthcare

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today reported that it received the initial purchase order relating to taiba Healthcare's early access program for Endari(R)...

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Announces Update of its Partnership with taiba Healthcare to Expand Patient Access for Sickle Cell Disease Treatment in the Middle East and North Africa (MENA) Region

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today reported that it expects to receive shortly the initial purchase orders relating to taiba Healthcare's early access...

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Reports 2019 Third Quarter Financial Results

-- Net Revenues Increased 25% Year-Over-Year,

EMMA : 1.6300 (-4.12%)
Delisting of Securities of On Track Innovations Ltd, Destination Maternity Corporation, Emmaus Life Sciences, Inc., China Lending Corporation, ChinaCache International Holdings Ltd. and the Warrant of DermTech, Inc. from The Nasdaq Stock Market

The Nasdaq Stock Market announced today that it will delist the ordinary shares of On Track Innovations Ltd. On Track Innovations Ltd's stock was suspended on October 31, 2019 and has not traded on Nasdaq...

CLDC : 0.38 (-6.66%)
CCIH : 0.88 (-19.65%)
DEST : 0.11 (-31.21%)
EMMA : 1.6300 (-4.12%)
NDAQ : 109.14 (-0.10%)
OTIV : 0.17 (-5.56%)
Emmaus Life Sciences Announces Equity Investment from a Corporate Investor

Company Enters Into Common Stock Purchase Agreement with Vivozon, Inc.

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended September 30, 2019

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, today reported preliminary gross sales results of $7.0 million for the third quarter ended September 30, 2019...

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Granted Patent in India for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the allowance by the Indian Patent Office of its patent application (serial number 1255/KOLNP/2014)...

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today announced it is approved to have its common stock trade on the OTCQB marketplace, effective September 26, 2019....

EMMA : 1.6300 (-4.12%)
Emmaus Life Sciences Reinforces Positive Outcomes of Endari ® Clinical Trials, Including Efficacy Findings That Led to FDA Approval

TORRANCE, Calif. , Sept. 24, 2019 /PRNewswire/ --  Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease (SCD) treatment, today released the following summary review of the...

EMMA : 1.6300 (-4.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EMMA with:

Key Turning Points

2nd Resistance Point 1.7100
1st Resistance Point 1.6700
Last Price 1.6300
1st Support Level 1.6100
2nd Support Level 1.5900

See More

52-Week High 12.9000
Fibonacci 61.8% 8.4803
Fibonacci 50% 7.1150
Fibonacci 38.2% 5.7497
Last Price 1.6300
52-Week Low 1.3300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar